Oric Pharmaceuticals Stock Market Value
| ORIC Stock | USD 9.59 0.47 5.15% |
| Symbol | Oric |
Oric Pharmaceuticals Price To Book Ratio
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Oric Pharmaceuticals. If investors know Oric will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Oric Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.82) | Return On Assets (0.29) | Return On Equity (0.46) |
The market value of Oric Pharmaceuticals is measured differently than its book value, which is the value of Oric that is recorded on the company's balance sheet. Investors also form their own opinion of Oric Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Oric Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Oric Pharmaceuticals' market value can be influenced by many factors that don't directly affect Oric Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Oric Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Oric Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Oric Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Oric Pharmaceuticals 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Oric Pharmaceuticals' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Oric Pharmaceuticals.
| 10/24/2024 |
| 11/23/2024 |
If you would invest 0.00 in Oric Pharmaceuticals on October 24, 2024 and sell it all today you would earn a total of 0.00 from holding Oric Pharmaceuticals or generate 0.0% return on investment in Oric Pharmaceuticals over 30 days. Oric Pharmaceuticals is related to or competes with Lyra Therapeutics, Hookipa Pharma, SAB Biotherapeutics, Cadrenal Therapeutics,, and Coherus BioSciences. ORIC Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for treatment o... More
Oric Pharmaceuticals Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Oric Pharmaceuticals' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Oric Pharmaceuticals upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.04) | |||
| Maximum Drawdown | 23.18 | |||
| Value At Risk | (6.32) | |||
| Potential Upside | 6.04 |
Oric Pharmaceuticals Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Oric Pharmaceuticals' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Oric Pharmaceuticals' standard deviation. In reality, there are many statistical measures that can use Oric Pharmaceuticals historical prices to predict the future Oric Pharmaceuticals' volatility.| Risk Adjusted Performance | 0.0014 | |||
| Jensen Alpha | (0.24) | |||
| Total Risk Alpha | (0.55) | |||
| Treynor Ratio | (0.02) |
Oric Pharmaceuticals Backtested Returns
Oric Pharmaceuticals maintains Sharpe Ratio (i.e., Efficiency) of -0.0052, which implies the firm had a -0.0052% return per unit of risk over the last 3 months. Oric Pharmaceuticals exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check Oric Pharmaceuticals' Variance of 15.24, risk adjusted performance of 0.0014, and Coefficient Of Variation of (11,488) to confirm the risk estimate we provide. The company holds a Beta of 1.94, which implies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Oric Pharmaceuticals will likely underperform. At this point, Oric Pharmaceuticals has a negative expected return of -0.0199%. Please make sure to check Oric Pharmaceuticals' treynor ratio, accumulation distribution, period momentum indicator, as well as the relationship between the potential upside and day median price , to decide if Oric Pharmaceuticals performance from the past will be repeated at some point in the near future.
Auto-correlation | -0.69 |
Very good reverse predictability
Oric Pharmaceuticals has very good reverse predictability. Overlapping area represents the amount of predictability between Oric Pharmaceuticals time series from 24th of October 2024 to 8th of November 2024 and 8th of November 2024 to 23rd of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Oric Pharmaceuticals price movement. The serial correlation of -0.69 indicates that around 69.0% of current Oric Pharmaceuticals price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.69 | |
| Spearman Rank Test | -0.53 | |
| Residual Average | 0.0 | |
| Price Variance | 0.52 |
Oric Pharmaceuticals lagged returns against current returns
Autocorrelation, which is Oric Pharmaceuticals stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Oric Pharmaceuticals' stock expected returns. We can calculate the autocorrelation of Oric Pharmaceuticals returns to help us make a trade decision. For example, suppose you find that Oric Pharmaceuticals has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Oric Pharmaceuticals regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Oric Pharmaceuticals stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Oric Pharmaceuticals stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Oric Pharmaceuticals stock over time.
Current vs Lagged Prices |
| Timeline |
Oric Pharmaceuticals Lagged Returns
When evaluating Oric Pharmaceuticals' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Oric Pharmaceuticals stock have on its future price. Oric Pharmaceuticals autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Oric Pharmaceuticals autocorrelation shows the relationship between Oric Pharmaceuticals stock current value and its past values and can show if there is a momentum factor associated with investing in Oric Pharmaceuticals.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Oric Pharmaceuticals offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Oric Pharmaceuticals' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Oric Pharmaceuticals Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Oric Pharmaceuticals Stock:Check out Oric Pharmaceuticals Correlation, Oric Pharmaceuticals Volatility and Oric Pharmaceuticals Alpha and Beta module to complement your research on Oric Pharmaceuticals. For information on how to trade Oric Stock refer to our How to Trade Oric Stock guide.You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.
Oric Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.